Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04087018
Title Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Arcus Biosciences, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Southern California Permanente Medical Group Riverside California 92120 United States Details
Kaiser Permanente (NorCal) - Roseville Roseville California 95661 United States Details
Christiana Care Health System - Helen F. Graham Cancer Center Newark Delaware 19713 United States Details
Kaiser Permanente Mid-Atlantic Gaithersburg Maryland 20879 United States Details
Metro MN CCOP Saint Louis Park Minnesota 55416 United States Details
Lehigh Valley Hospital Allentown Pennsylvania 18103 United States Details
Prisma Health Greenville South Carolina 29605 United States Details
Saint Francis Cancer Center Greenville South Carolina 29607 United States Details
Gundersen Lutheran Medical Center La Crosse Wisconsin 54601 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field